miércoles, 30 de marzo de 2016

National Guideline Clearinghouse | ACR Appropriateness Criteria® Hodgkin lymphoma—unfavorable clinical stage I and II.

National Guideline Clearinghouse | ACR Appropriateness Criteria® Hodgkin lymphoma—unfavorable clinical stage I and II.



American College of Radiology
National Guideline Clearinghouse (NGC)

Guideline Title
ACR Appropriateness Criteria® Hodgkin lymphoma—unfavorable clinical stage I and II.
Bibliographic Source(s)
Roberts KB, Younes A, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Constine LS, Expert Panel on Radiation Oncology–Lymphoma. ACR Appropriateness Criteria® Hodgkin lymphoma - unfavorable clinical stage I and II. Reston (VA): American College of Radiology (ACR); 2015. 22 p. [83 references]
Guideline Status
This is the current release of the guideline.
This guideline updates a previous version: Das P, Ng A, Constine LS, Advani R, Flowers C, Friedberg J, Hodgson DC, Schwartz CL, Wilder RB, Wilson LD, Yunes MJ, Expert Panel on Radiation Oncology-Hodgkin's Lymphoma. ACR Appropriateness Criteria® Hodgkin's lymphoma - unfavorable clinical stage I and II. [online publication]. Reston (VA): American College of Radiology (ACR); 2010. 6 p. [24 references]
This guideline meets NGC's 2013 (revised) inclusion criteria.

No hay comentarios:

Publicar un comentario